13.12.2012 Views

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(A61K) I.1(1)<br />

(30) 18.05.2006 US 801365 P<br />

(54) • RASCHER NACHWEIS VON MYKOBAK-<br />

TERIUMTUBERKULOSE UND RESISTENZ<br />

GEGEN ANTIMIKROBIKA<br />

• RAPID DETECTION OF MYCOBACTERIUM<br />

TUBERCULOSIS AND ANTIMICROBIAL<br />

DRUG RESISTANCE<br />

• PROCÉDÉ DE DÉTECTION RAPIDE DE<br />

MYCOBACTERIUM TUBERCULOSIS ET DE<br />

RÉSISTANCE À UN MÉDICAMENT ANTI-<br />

MICROBIEN<br />

(71) Ericson, Daniel G., 1423 Bell Oaks Lane SW,<br />

Rochester, MN 55902, US<br />

(72) Ericson, Daniel G., Rochester, MN 55902, US<br />

(74) Maggs, Michael Norman, et al, Kilburn &<br />

Strode 20 Red Lion Street, London WC1R<br />

4PJ, GB<br />

(51) A61K 39/00 (11) 2 021 019 A2*<br />

C<strong>07</strong>H 21/04<br />

(25) En (26) En<br />

(21) <strong>07</strong>794887.5 (22) 15.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/011623 15.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/133773 20<strong>07</strong>/47 22.11.20<strong>07</strong><br />

(30) 15.05.2006 US 747213 P<br />

(54) • IDENTIFIZIERUNG VON CDKI-PFAD-HEM-<br />

MERN<br />

• IDENTIFICATION OF CDKI PATHWAY<br />

INHIBITORS<br />

• IDENTIFICATION D'INHIBITEURS DE VOIE<br />

DES CDKI<br />

(71) Senex Biotechnology, Inc., 150 New Scotland<br />

Avenue, Albany, New York 12208, US<br />

(72) CHANG, Bey-Dih, Rensselaer, NY 12208, US<br />

RONINSON, Igor, B., Loudonville, NY 12208,<br />

US<br />

(74) Portal, Frédéric, et al, Cabinet Beau de<br />

Loménie 158, rue de l'Université, 75340<br />

Paris Cedex <strong>07</strong>, FR<br />

A61K 39/00 → (51) A61K 31/70<br />

A61K 39/00 → (51) A61K 48/00<br />

A61K 39/00 → (51) C12N 15/10<br />

A61K 39/00 → (51) C12N 15/866<br />

A61K 39/00 → (51) C12Q 1/68<br />

(51) A61K 39/02 (11) 2 021 020 A2*<br />

A61P 31/04<br />

(25) En (26) En<br />

(21) <strong>07</strong>873984.4 (22) 08.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/011208 08.05.20<strong>07</strong><br />

(87) WO 2008/111943 2008/38 18.09.2008<br />

(30) 12.05.2006 US 800099 P<br />

(54) • ABGESONDERTE CAMPYLOBACTER-FLA-<br />

GELLA-CO-REGULIERTE PROTEINE ALS<br />

IMMUNOGENE<br />

• SECRETED CAMPYLOBACTER FLAGELLA<br />

COREGULATED PROTEINS AS IMMUNO-<br />

GENS<br />

• PROTÉINES CORÉGULÉES SÉCRÉTÉES<br />

PAR CAMPYLOBACTER FLAGELLA EN<br />

TANT QU'IMMUNOGÈNES<br />

(71) The United States Of America, As Represented<br />

By The Secretary Of The Navy, Naval<br />

Medical Research Center 503 Robert Grant<br />

Avenue, Silver Spring, MD 20910, US<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(72) GUERRY-KOPECKO, Patricia, Silver Spring,<br />

MD 20906, US<br />

BAQAR, Shahida, Olney, MD 20832, US<br />

(74) Schumacher, Horst, et al, Grosse - Schumacher<br />

- Knauer - von Hirschhausen <strong>Patent</strong>und<br />

Rechtsanwälte Frühlingstrasse 43 A,<br />

45133 Essen, DE<br />

A61K 39/02 → (51) A61K 39/00<br />

A61K 39/04 → (51) A61K 39/00<br />

(51) A61K 39/<strong>07</strong> (11) 2 021 021 A2*<br />

(25) En (26) En<br />

(21) <strong>07</strong>794875.0 (22) 14.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/011608 14.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/145760 20<strong>07</strong>/51 21.12.20<strong>07</strong><br />

(88) 17.<strong>07</strong>.2008<br />

(30) 12.05.2006 US 799819 P<br />

(54) • ANTHRAX-ZUSAMMENSETZUNGEN UND<br />

VERFAHREN ZU IHRER HERSTELLUNG<br />

UND ANWENDUNG<br />

• ANTHRAX COMPOSITIONS AND METH-<br />

ODS OF USE AND PRODUCTION<br />

• COMPOSITIONS CONTRE L'ANTHRAX ET<br />

PROCÉDÉS D'UTILISATION ET DE PRO-<br />

DUCTION DE CELLES-CI<br />

(71) Oklahoma Medical Research Foundation, 825<br />

N.E. 13th Street, Oklahoma City, OK 73104,<br />

US<br />

Farris, Darise, 16037 Teesdale Road,<br />

Edmond, OK 73013, US<br />

(72) JAMES, Judith, A., Edmond, OK 73013, US<br />

CROWE, Sherry, Midwest City, OK 73110,<br />

US<br />

(74) Baldock, Sharon Claire, BOULT WADE TEN-<br />

NANT Verulam Gardens 70 Gray's Inn Road,<br />

London WC1X 8BT, GB<br />

A61K 39/<strong>07</strong> → (51) C12P 21/00<br />

(51) A61K 39/08 (11) 2 021 022 A2*<br />

(25) En (26) En<br />

(21) <strong>07</strong>784000.7 (22) 21.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/069391 21.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/137235 20<strong>07</strong>/48 29.11.20<strong>07</strong><br />

(88) 22.05.2008<br />

(30) 19.05.2006 US 747771 P<br />

18.05.20<strong>07</strong> US 750967<br />

18.05.20<strong>07</strong> US 750963<br />

(54) • VORRICHTUNG, VERFAHREN UND SYS-<br />

TEME ZUR TOXINFREISETZUNG IN DER<br />

NASENHÖHLE<br />

• APPARATUS, METHODS AND SYSTEMS<br />

FOR TOXIN DELIVERY TO THE NASAL<br />

CAVITY<br />

• APPAREIL, PROCÉDÉS ET SYSTÈMES<br />

POUR L'ADMINISTRATION DE TOXINE À<br />

LA CAVITÉ NASALE<br />

(71) The Foundry, Inc., 199 Jefferson Drive,<br />

Menlo Park, CA 94025, US<br />

(72) DEEM, Mark, E., Mountain View, California<br />

94041, US<br />

GIFFORD, Hanson, Woodside, California<br />

94062, US<br />

KIM, Steven, Los Altos, California 94024, US<br />

SALAMINI, Alexey, San Francisco, California<br />

94110, US<br />

(74) Clark, Jane Anne, et al, Mathys & Squire<br />

LLP, 120 Holborn London EC1N 2SQ, GB<br />

42<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>07</strong>/<strong>2009</strong>) 11.02.<strong>2009</strong><br />

A61K 39/21 → (51) C<strong>07</strong>K 14/16<br />

(51) A61K 39/275 (11) 2 021 023 A2*<br />

C12Q 1/70<br />

(25) En (26) En<br />

(21) <strong>07</strong>798014.2 (22) 01.06.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/<strong>07</strong>0219 01.06.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/143548 20<strong>07</strong>/50 13.12.20<strong>07</strong><br />

(88) 25.09.2008<br />

(30) 01.06.2006 US 803640 P<br />

(54) • MYXOM-VIRUSMUTANTEN ZUR KREBS-<br />

BEHANDLUNG<br />

• MYXOMA VIRUS MUTANTS FOR CANCER<br />

TREATMENT<br />

• MUTANTS DE VIRUS DU MYXOME DES-<br />

TINÉS AU TRAITEMENT DU CANCER<br />

(71) Robarts Research Institute, 100 Perth Drive<br />

P.O. Box 5015, London, Ontario N6A 5K8,<br />

CA<br />

(72) BARRETT, John, W., London, ON N6G 1W9,<br />

CA<br />

MCFADDEN, Grant, Gainesville, FL 32605,<br />

US<br />

(74) MacLean, Martin Robert, Mathys & Squire<br />

LLP 120 Holborn, London EC1N 2SQ, GB<br />

(51) A61K 39/385 (11) 2 021 024 A1*<br />

A61K 47/06<br />

(25) En (26) En<br />

(21) <strong>07</strong>729056.7 (22) 11.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) EP 20<strong>07</strong>/054604 11.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/131972 20<strong>07</strong>/47 22.11.20<strong>07</strong><br />

(30) 12.05.2006 EP 06113895<br />

(54) • NIKOTIN-TRÄGER-VAKZINE-FORMULIE-<br />

RUNG<br />

• NICOTINE-CARRIER VACCINE FORMULA-<br />

TION<br />

• FORMULE DE VACCIN VÉHICULANT DE LA<br />

NICOTINE<br />

(71) Cytos Biotechnology AG, Wagistrasse 25,<br />

8952 Schlieren, CH<br />

(72) LANG, Rainer, 81371 München, DE<br />

WINTER, Gerhard, 82377 Penzberg, DE<br />

VOGT, Lorenz, 8344 Bäretswil, CH<br />

(74) Graff, Alan, Novartis Pharma AG <strong>Patent</strong><br />

Department, 4002 Basel, CH<br />

A61K 39/39 → (51) A61K 48/00<br />

(51) A61K 39/395 (11) 2 021 025 A1*<br />

A61M 1/36 A61P 1/04<br />

(25) En (26) En<br />

(21) <strong>07</strong>748123.2 (22) 14.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) SE 20<strong>07</strong>/000459 14.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/133147 20<strong>07</strong>/47 22.11.20<strong>07</strong><br />

(30) 12.05.2006 SE 0601<strong>07</strong>5<br />

(54) • VERFAHREN UND MITTEL ZUR BEHAND-<br />

LUNG VON ENTZÜNDLICHER DARMER-<br />

KRANKUNG<br />

• METHOD AND MEANS FOR TREATING<br />

INFLAMMATORY BOWEL DISEASE<br />

• PROCÉDÉ ET MOYENS POUR TRAITER<br />

LES MALADIES INFLAMMATOIRES<br />

CHRONIQUES DE L'INTESTIN

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!